September 29, 2021 Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review C-Path's Huntington's Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based...
September 24, 2021 Critical Path for Parkinson’s Consortium 3DT Initiative: Recommendations for involving people with Parkinson’s in clinical studies using digital health tools Recommendations for involving people with Parkinson’s in clinical studies using digital health tools
September 16, 2021 C-Path Appoints Tufts’ Jonathan M. Davis as Senior Advisor in Pediatrics TUCSON, Ariz., September 16, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jonathan M. Davis, M.D.,
September 15, 2021 Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program C-Path, NORD and FDA host annual meeting, demonstration and launch of new rare disease data and analytics platform. TUCSON, Ariz.
September 14, 2021 VIEW NOW | 2021 RDCA-DAP® Workshop The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerat
September 14, 2021 Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
September 13, 2021 C-Path and RARE-X Establish New Collaboration for Rare Disease Data Sharing RARE-X and Critical Path Institute align on their mission and commitment for data sharing to improve rare disease research TUCSON,
September 1, 2021 Breaking Down Data Siloes: New Analytics Platform Sparks Opportunity for Rare Disease Field C-Path, NORD and FDA have spent two years building the platform set to launchSept. 14 at the 2021 RDCA-DAP Workshop. TUCSON, Ariz.
August 25, 2021 WEBINAR | Alternative Solutions in Safety Assessment When: August 25, 2021, 10 – 11:30 a.m. ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi
August 23, 2021 ePRO Consortium Welcomes Medable C-Path is proud to welcome Medable, Inc as the newest member of its Electronic Patient-Reported Outcome Consortium. Compr